Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase NA 4Phase 1/2 2Phase 2/3 1Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 320Leukemia, Myeloid, Acute 266Multiple Myeloma 227Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 202Neoplasms 196Lymphoma 191Colorectal Neoplasms 184Melanoma 179Leukemia 170Recurrence 164Pancreatic Neoplasms 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 160Lung Neoplasms 150Glioblastoma 134Neoplasm Metastasis 132Lymphoma, Non-Hodgkin 128Ovarian Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 120Myelodysplastic Syndromes 117Lymphoma, Large B-Cell, Diffuse 110Lymphoma, Mantle-Cell 108Carcinoma, Hepatocellular 103Lymphoma, Follicular 99Stomach Neoplasms 96Carcinoma, Renal Cell 89Hodgkin Disease 88Brain Neoplasms 88Sarcoma 84Burkitt Lymphoma 75

Interventions

Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Psoriasis × Clear all
NCT00585650 2023-08-18

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

University of California, Irvine

Phase 1/2 Completed
20 enrolled 5 charts

Psoriasis

NCT00129415 2015-05-22

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

University of Michigan

Phase 1/2 Terminated
28 enrolled
DermatologicLymphoid

Alopecia, Dermatitis, Atopic, Mycosis Fungoides, Psoriasis, Skin Diseases, Urticaria, Lymphoma, T-Cell, Cutaneous, Striae Distensae

Data powered by HemOnc (CC BY 4.0) Colophon âš¡